RNA Mediated toll-like receptor stimulation in health and disease
Open accessAbstract
Besides their well known functions in storage and translation of information nucleic acids have emerged as a target of pattern recognition receptors that drive activation of innate immunity. Due to the paucity of building block monomers used in nucleic acids, discrimination of host and microbial nucleic acids as a means of self/foreign discrimination is a complicated task. Pattern recognition receptors rely on discrimination by sequence, structural features and spatial compartmentalization to differentiate microbial derived nucleic acids from host ones. Microbial nucleic acid detection is important for the sensing of infectious danger and initiating an immune response to microbial attack. Failures in the underlying recognitions systems can have severe consequences: thus, inefficient recognition of microbial nucleic acids may increase susceptibility to infectious diseases. On the other hand, excessive immune responses as a result of failed self/foreign discrimination are associated with autoimmune diseases. This review gives a general overview over the underlying concepts of nucleic acid sensing by Toll-like receptors. Within this general framework, we focus on bacterial RNA and synthetic RNA oligomers.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Unmodified mRNA itself provides adjuvant activity through binding and activation of the innate immune sensors, mainly TLRs 3, 7, and 8.
“Unmodified mRNA itself provides adjuvant activity through binding and activation of the innate immune sensors, mainly TLRs 3, 7, and 8 (39).”
From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [39]
The section on posttranscriptional modifications reports that RNA activates TLR3, TLR7 and TLR8, and that certain modifications suppress this activation. The section on synthetic RNA identifies potential vaccine-adjuvant activity, but it discusses RNA oligonucleotides rather than establishing that unmodified mRNA itself provides adjuvant activity mainly through those three receptors. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · see citing works
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · see citing works
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · see citing works
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in <i>Tlr4</i> Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · see citing works
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · see citing works
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137 · see citing works
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · see citing works
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · see citing works
Lemaître, B., Nicolas, E., Michaut, L., Reichhart, J., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,027 · see citing works
Plant pathogens and integrated defence responses to infection
Dangl, J. L., & Jones, J. D. G. (2001) · Nature · doi:10.1038/35081161 · Cited by 3,959 · see citing works
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947 · see citing works
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,935 · see citing works
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888 · see citing works
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · see citing works
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508 · see citing works
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444 · see citing works
Approaching the asymptote? Evolution and revolution in immunology.Preprint
Janeway, C. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,396 · see citing works
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728 · see citing works
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667 · see citing works
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · see citing works
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,517 · see citing works
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474 · see citing works
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,443 · see citing works
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B., Lee, H., & Lee, J. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,438 · see citing works
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne-Roussel, A., Thomas, G. D., Philpott, D. J., & Sansonetti, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200651200 · Cited by 2,397 · see citing works
Hornung, V., Rothenfußer, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,927 · see citing works
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · see citing works
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,899 · see citing works
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M. L., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,854 · see citing works
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831 · see citing works
IFI16 is an innate immune sensor for intracellular DNA
Unterholzner, L., Keating, S. E., Baran, M., Horan, K. A., Jensen, S. B., Sharma, S., Sirois, C. M., Jin, T., Latz, E., Xiao, T. S., et al. (2010) · Nature Immunology · doi:10.1038/ni.1932 · Cited by 1,643 · see citing works
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · see citing works
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579 · see citing works
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,401 · see citing works
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Czopik, A. K., Takeda, K., Akira, S., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,364 · see citing works
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · see citing works
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,355 · see citing works
Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide
Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S., Lee, H., & Lee, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.008 · Cited by 1,352 · see citing works
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
Yang, R.-B., Mark, M., Gray, A., Huang, A., Xie, M.-H., Zhang, M., Goddard, A., Wood, W., Gurney, A., & Godowski, P. (1998) · Nature · doi:10.1038/26239 · Cited by 1,319 · see citing works
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250 · see citing works
Hornung, V., Guenthner‐Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A. M., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,233 · see citing works
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J. M., Sato, A., Akira, S., Medzhitov, R. M., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,197 · see citing works
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190 · see citing works
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
Zhang, S., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P. J., Segal, D. M., Sancho‐Shimizu, V., Lorenzo, L., Puel, A., et al. (2007) · Science · doi:10.1126/science.1139522 · Cited by 1,165 · see citing works
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M. F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050500 · Cited by 1,126 · see citing works
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116 · see citing works
Bürckstümmer, T., Baumann, C., Blüml, S., Dixit, E., Dürnberger, G., Jahn, H., Planyavsky, M., Bilban, M., Colinge, J., Bennett, K. L., et al. (2009) · Nature Immunology · doi:10.1038/ni.1702 · Cited by 1,091 · see citing works
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090 · see citing works
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · see citing works
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., Lustig, D. S., & Cohn, Z. A. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.6.1431 · Cited by 1,052 · see citing works
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. Μ., Wagner, H., Lipford, G. B., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 1,017 · see citing works
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Tang, H., Nakaya, H. I., Ravindran, R., Stewart, S. M., Alam, M. S., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 970 · see citing works
Induction of an interferon response by RNAi vectors in mammalian cells
Bridge, A. J., Kaeser-Pebernard, S., Ducraux, A., Nicoulaz, A.-L., & Iggo, R. D. (2003) · Nature Genetics · doi:10.1038/ng1173 · Cited by 962 · see citing works
Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication
Pisitkun, P., Deane, J., Difilippantonio, M., Tarasenko, T. N., Satterthwaite, A., & Bolland, S. (2006) · Science · doi:10.1126/science.1124978 · Cited by 950 · see citing works
RNA-Based Therapeutics: Current Progress and Future Prospects
Burnett, J., & Rossi, J. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.008 · Cited by 910 · see citing works
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · see citing works
tRNAdb 2009: compilation of tRNA sequences and tRNA genes
Jühling, F., Mörl, M., Hartmann, R. K., Sprinzl, M., Stadler, P. F., & Pütz, J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn772 · Cited by 848 · see citing works
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
Roberts, T. L., Idris, A., Dunn, J. A., Kelly, G., Burnton, C. M., Hodgson, S., Hardy, L., Garceau, V., Sweet, M. J., Ross, I. L., et al. (2009) · Science · doi:10.1126/science.1169841 · Cited by 830 · see citing works
The RNA modification database, RNAMDB: 2011 update
Cantara, W. A., Crain, P. F., Rozenski, J., McCloskey, J. A., Harris, K. A., Zhang, X., Vendeix, F. A. P., Fabris, D., & Agris, P. F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1028 · Cited by 822 · see citing works
Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050630 · Cited by 813 · see citing works
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789 · see citing works
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
Kirschning, C. J., Wesche, H., Merrill Ayres, T., & Rothe, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2091 · Cited by 753 · see citing works
Control of B-cell responses by Toll-like receptors
Pasare, C., & Medzhitov, R. M. (2005) · Nature · doi:10.1038/nature04267 · Cited by 752 · see citing works
Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency
Casrouge, A., Zhang, S.-Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., Alcais, A., Picard, C., Mahfoufi, N., Nicolas, N., et al. (2006) · Science · doi:10.1126/science.1128346 · Cited by 749 · see citing works
Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB
Inohara, N., Koseki, T., del Peso, L., Hu, Y., Yee, C., Chen, S., Carrio, R., Merino, J., Liu, D., Ni, J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14560 · Cited by 742 · see citing works
Tabeta, K., Hoebe, K. H. N., Janssen, E. M., Du, X., Georgel, P., Crozat, K., Mudd, S., Mann, N., Sovath, S., Goode, J., et al. (2006) · Nature Immunology · doi:10.1038/ni1297 · Cited by 736 · see citing works
Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
Liu, L., Botos, I., Wang, Y., Leonard, J. N., Shiloach, J., Segal, D. M., & Davies, D. R. (2008) · Science · doi:10.1126/science.1155406 · Cited by 733 · see citing works
Krug, A., French, A. R., Barchet, W., Fischer, J. A. A., Dzionek, A., Pingel, J. T., Orihuela, M. M., Akira, S., Yokoyama, W. M., & Colonna, M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.007 · Cited by 727 · see citing works
A cell biological view of Toll-like receptor function: regulation through compartmentalization
Barton, G. M., & Kagan, J. C. (2009) · Nature reviews. Immunology · doi:10.1038/nri2587 · Cited by 713 · see citing works
Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells
Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H., Shingai, M., Seto, Y., Yamamoto, A., & Seya, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3154 · Cited by 708 · see citing works
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., Goedeke, L., Liu, X., et al. (2011) · Nature · doi:10.1038/nature10486 · Cited by 706 · see citing works
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
Kim, Y., Brinkmann, M. M., Paquet, M.-È., & Ploegh, H. L. (2008) · Nature · doi:10.1038/nature06726 · Cited by 699 · see citing works
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2003) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 696 · see citing works
Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
Kowalinski, E., Lunardi, T., McCarthy, A. A., Louber, J., Brunel, J., Grigorov, B., Gerlier, D., & Cusack, S. (2011) · Cell · doi:10.1016/j.cell.2011.09.039 · Cited by 689 · see citing works
HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
Yanai, H., Ban, T., Wang, Z., Choi, M. K., Kawamura, T., Negishi, H., Nakasato, M., Lu, Y., Hangai, S., Koshiba, R., et al. (2009) · Nature · doi:10.1038/nature08512 · Cited by 683 · see citing works
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682 · see citing works
Barton, G. M., Kagan, J. C., & Medzhitov, R. M. (2005) · Nature Immunology · doi:10.1038/ni1280 · Cited by 669 · see citing works
Deane, J. A., Pisitkun, P., Barrett, R. S., Feigenbaum, L., Town, T., Ward, J. M., Flavell, R. A., & Bolland, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.009 · Cited by 633 · see citing works
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 616 · see citing works
Mutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 598 · see citing works
Lee, J., Chuang, T., Redecke, V., She, L., Pitha, P. M., Carson, D. A., Raz, E., & Cottam, H. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631696100 · Cited by 594 · see citing works
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571 · see citing works
Lövgren, T., Eloranta, M., Båve, U., Alm, G. V., & Rönnblom, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20254 · Cited by 553 · see citing works
Tolerance for mutations and chemical modifications in a siRNA
Amarzguioui, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg147 · Cited by 534 · see citing works
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K. J., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531 · see citing works
Persengiev, S. P., Zhu, X., & Green, M. R. (2003) · RNA · doi:10.1261/rna5160904 · Cited by 531 · see citing works
Activation of Autoreactive B Cells by CpG dsDNA
Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., & Marshak‐Rothstein, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00323-6 · Cited by 519 · see citing works
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M. J., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516 · see citing works
Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K. M., Reeves, W. H., Bauer, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051696 · Cited by 515 · see citing works
MODOMICS: a database of RNA modification pathways
Dunin-Horkawicz, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj084 · Cited by 511 · see citing works
Park, B., Brinkmann, M. M., Spooner, E., Lee, C. C., Kim, Y., & Ploegh, H. L. (2008) · Nature Immunology · doi:10.1038/ni.1669 · Cited by 478 · see citing works
The Inflammasome: First Line of the Immune Response to Cell Stress
Ogura, Y., Sutterwala, F. S., & Flavell, R. A. (2006) · Cell · doi:10.1016/j.cell.2006.08.002 · Cited by 474 · see citing works
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Baccalà, R., Hoebe, K. H. N., Kono, D. H., Beutler, B., & Theofilopoulos, A. N. (2007) · Nature Medicine · doi:10.1038/nm1590 · Cited by 471 · see citing works
Karikó, K., Bhuyan, P. K., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 446 · see citing works
Brinkmann, M. M., Spooner, E., Hoebe, K. H. N., Beutler, B., Ploegh, H. L., & Kim, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612056 · Cited by 444 · see citing works
Motorin, Y., & Helm, M. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.79 · Cited by 441 · see citing works
Chemically modified siRNA: tools and applications
Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431 · see citing works
Structural Insights into RNA Recognition by RIG-I
Luo, D., Ding, S. C., Vela, A., Kohlway, A. S., Lindenbach, B. D., & Pyle, A. M. (2011) · Cell · doi:10.1016/j.cell.2011.09.023 · Cited by 423 · see citing works
Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 415 · see citing works
Ku, C., von Bernuth, H., Pïcard, C., Zhang, S., Chang, H., Yang, K., Chrabieh, M., Issekutz, A. C., Cunningham, C. K., Gallin, J. I., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070628 · Cited by 399 · see citing works
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Poeck, H., Besch, R., Maihoefer, C., Renn, M., Tormo, D., Morskaya, S. S., Kirschnek, S., Gaffal, E., Landsberg, J., Hellmuth, J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1887 · Cited by 387 · see citing works
Marques, J. T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M. A., & Williams, B. R. G. (2006) · Nature Biotechnology · doi:10.1038/nbt1205 · Cited by 380 · see citing works
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Guiducci, C., Gong, M., Xu, Z., Gill, M. A., Chaussabel, D., Meeker, T., Chan, J. H., Wright, T. B., Punaro, M., Bolland, S. M., et al. (2010) · Nature · doi:10.1038/nature09102 · Cited by 380 · see citing works
Lipford, G. B., Bauer, M., Blank, C. A., Reiter, R., Wagner, H., & Heeg, K. M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270931 · Cited by 378 · see citing works
Brentano, F., Schorr, O., Gay, R. E., Gay, S., & Kyburz, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21273 · Cited by 377 · see citing works
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease
Lang, K. S., Recher, M., Junt, T., Navarini, A. A., Harris, N. L., Freigang, S., Odermatt, B., Conrad, C., Ittner, L. M., Bauer, S., et al. (2005) · Nature Medicine · doi:10.1038/nm1176 · Cited by 377 · see citing works
Approaching the Asymptote: 20 Years Later
Medzhitov, R. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.004 · Cited by 367 · see citing works
Human CARD4 Protein Is a Novel CED-4/Apaf-1 Cell Death Family Member That Activates NF-κB
Bertin, J., Nir, W.-J., Fischer, C., Tayber, O., Errada, P. R., Grant, J. R., Keilty, J., Gosselin, M., Robison, K. E., Wong, G. H., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.12955 · Cited by 366 · see citing works
Activation of the mammalian immune system by siRNAs
Marques, J. T., & Williams, B. R. G. (2005) · Nature Biotechnology · doi:10.1038/nbt1161 · Cited by 357 · see citing works
Anderson, B. R., Muramatsu, H., Jha, B. K., Silverman, R. H., Weissman, D., & Kariko, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr586 · Cited by 356 · see citing works
Kerkmann, M., Rothenfußer, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., Giese, T., Endres, S., & Hartmann, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4465 · Cited by 351 · see citing works
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells
Mancuso, G., Gambuzza, M. E., Midiri, A., Biondo, C., Papasergi, S., Akira, S., Teti, G., & Beninati, C. (2009) · Nature Immunology · doi:10.1038/ni.1733 · Cited by 351 · see citing works
2′-O-methyl-modified RNAs Act as TLR7 Antagonists
Robbins, M., Judge, A. D., Liang, L. Y., McClintock, K., Yaworski, E., & MacLachlan, I. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300240 · Cited by 339 · see citing works
Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
Forsbach, A., Némorin, J.-G., Montino, C., Müller, C., Samulowitz, U., Vicari, A. P., Jurk, M., Mutwiri, G., Krieg, A. Μ., Lipford, G. B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3729 · Cited by 316 · see citing works
Ewald, S. E., Engel, A., Lee, J., Wang, M., Bogyo, M. S., & Barton, G. M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100682 · Cited by 314 · see citing works
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
Wagner, H. (1999) · Advances in immunology · doi:10.1016/s0065-2776(08)60790-7 · Cited by 313 · see citing works
The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
Haas, T. L., Metzger, J., Schmitz, F., Heit, A., Müller, T. R., Latz, E., & Wagner, H. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.013 · Cited by 298 · see citing works
A status report on RNAi therapeutics
Vaishnaw, A. K., Gollob, J., Gamba‐Vitalo, C., Hutabarat, R. M., Sah, D. W. Y., Meyers, R. E., de Fougerolles, T., & Maraganore, J. M. (2010) · Silence · doi:10.1186/1758-907x-1-14 · Cited by 297 · see citing works
Diebold, S. S., Massacrier, C., Akira, S., Paturel, C., Morel, Y., & Sousa, C. R. E. (2006) · European Journal of Immunology · doi:10.1002/eji.200636617 · Cited by 281 · see citing works
Sepulveda, F. E., Maschalidi, S., Colisson, R., Heslop, L., Ghirelli, C., Sakka, E., Lennon‐Duménil, A., Amigorena, S., Cabanié, L., & Manoury, B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.013 · Cited by 280 · see citing works
The TLR3 signaling complex forms by cooperative receptor dimerization
Leonard, J. N., Ghirlando, R., Askins, J., Bell, J. K., Margulies, D. H., Davies, D. R., & Segal, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710779105 · Cited by 279 · see citing works
Phosphorothioation of DNA in bacteria by dnd genes
Wang, L., Chen, S., Xu, T., Taghizadeh, K., Wishnok, J. S., Zhou, X., You, D., Deng, Z., & Dedon, P. C. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.39 · Cited by 274 · see citing works
Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C., Casrouge, A., Pïcard, C., von Bernuth, H., Sénéchal, B., Plancoulaine, S., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.016 · Cited by 273 · see citing works
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice.
Berland, R., Fernandez, L., Kari, E., Han, J.-H., Lomakin, I., Akira, S., Wortis, H., Kearney, J., Ucci, A., & Imanishi-Kari, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.014 · Cited by 269 · see citing works
de BOUTEILLER, O., Merck, E., Hasan, U. A., Hubac, S., Benguigui, B., Trinchieri, G., Bates, E. E. M., & Caux, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507163200 · Cited by 260 · see citing works
Innate Immune Recognition of an AT-Rich Stem-Loop DNA Motif in the Plasmodium falciparum Genome
Sharma, S., DeOliveira, R. B., Kalantari, P., Parroche, P., Goutagny, N., Jiang, Z., Chan, J., Bartholomeu, D. C., Lauw, F. N., Hall, J. P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.016 · Cited by 258 · see citing works
Fukui, R., Saitoh, S.-I., Matsumoto, F., Kozuka‐Hata, H., Oyama, M., Tabeta, K., Beutler, B., & Miyake, K. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082316 · Cited by 255 · see citing works
Nishiya, T., & DeFranco, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311618200 · Cited by 236 · see citing works
TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus
Lee, P. Y., Kumagai, Y., Li, Y., Takeuchi, O., Yoshida, H., Weinstein, J. S., Kellner, E. S., Nacionales, D. C., Barker, T. T., Kelly‐Scumpia, K. M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080462 · Cited by 220 · see citing works
CD14 is a coreceptor of Toll-like receptors 7 and 9
Baumann, C., Aspalter, I. M., Sharif, O., Pichlmair, A., Blüml, S., Grebien, F., Brückner, M., Pasierbek, P., Aumayr, K., Planyavsky, M., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101111 · Cited by 220 · see citing works
Fukui, R., Saitoh, S.-I., Kanno, A., Onji, M., Shibata, T., Ito, A., Onji, M., Matsumoto, M., Akira, S., Yoshida, N., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.010 · Cited by 217 · see citing works
Isnardi, I., Ng, Y.-S., Srdanovic, I., Motaghedi, R., Rudchenko, S., von Bernuth, H., Zhang, S., Puel, A., Jouanguy, E., Pïcard, C., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.015 · Cited by 216 · see citing works
siRNA and isRNA: two edges of one sword
Schlee, M., Hornung, V., & Hartmann, G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.001 · Cited by 215 · see citing works
Activation of anti-hepatitis C virus responses via Toll-like receptor 7
Lee, J., Wu, C. C. N., Lee, K. J., Chuang, T., Katakura, K., Liu, Y., Chan, M. D., Tawatao, R. I., Chung, M. T. M., Shen, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510801103 · Cited by 212 · see citing works
Sioud, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200535708 · Cited by 203 · see citing works
MODOMICS: a database of RNA modification pathways. 2008 update
Czerwoniec, A., Dunin-Horkawicz, S., Purta, E., Kaminska, K. H., Kasprzak, J. M., Bujnicki, J. M., Grosjean, H., & Rother, K. M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn710 · Cited by 199 · see citing works
Diken, M., Kreiter, S., Selmi, A., Britten, C. M., Huber, C. G., Türeci, Ö., & Şahin, U. (2011) · Gene Therapy · doi:10.1038/gt.2011.17 · Cited by 192 · see citing works
Host Defense Pathways: Role of Redundancy and Compensation in Infectious Disease Phenotypes
Nish, S. A., & Medzhitov, R. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.009 · Cited by 186 · see citing works
Lack of interferon response in animals to naked siRNAs
Heidel, J. D., Hu, S., Liu, X. F., Triche, T. J., & Davis, M. E. (2004) · Nature Biotechnology · doi:10.1038/nbt1038 · Cited by 183 · see citing works
Innate sensing of self and non-self RNAs by Toll-like receptors
Sioud, M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.02.004 · Cited by 180 · see citing works
Kerkmann, M., Costa, L. T., Richter, C. E., Rothenfußer, S., Battiany, J., Hornung, V., Johnson, J. P., Englert, S., Ketterer, T., Heckl, W. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410868200 · Cited by 177 · see citing works
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling
Lang, K. S., Georgiev, P., Recher, M., Navarini, A. A., Bergthaler, A., Heikenwälder, M. F., Harris, N. L., Junt, T., Odermatt, B., Clavien, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28349 · Cited by 173 · see citing works
TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages
Gantier, M. P., Tong, S. Y. C., Behlke, M. A., Xu, D., Phipps, S., Foster, P. S., & Williams, B. R. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2117 · Cited by 159 · see citing works
Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs
Sioud, M., Furset, G., & Cekaite, L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.177 · Cited by 149 · see citing works
Immunostimulating capacities of stabilized RNA molecules
Scheel, B., Braedel, S., Probst, J., Carralot, J., Wagner, H., Schild, H., Jung, G., Rammensee, H., & Pascolo, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200324198 · Cited by 138 · see citing works
Strumberg, D., Schultheis, B. S., Traugott, U., Vank, C., Santel, A., Keil, O., Giese, K., Kaufmann, J., & Drevs, J. (2011) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp50076 · Cited by 137 · see citing works
A novel DNA modification by sulphur
Zhou, X., He, X., Liang, J., Li, A., Xu, T., Kieser, T., Helmann, J. D., & Deng, Z. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04764.x · Cited by 131 · see citing works
Gratz, N., Hartweger, H., Matt, U., Kratochvill, F., Janos, M., Sigel, S., Drobits, B., Li, X.-D., Knapp, S., & Kovarik, P. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001345 · Cited by 131 · see citing works
Karikó, K., & Weissman, D. (2007) · PubMed · Cited by 130 · see citing works
Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity
Gehrig, S. M., Eberle, M.-E., Botschen, F., Rimbach, K., Eberle, F., Eigenbrod, T., Kaiser, S., Holmes, W. M., Erdmann, V. A., Sprinzl, M., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111044 · Cited by 126 · see citing works
Binder, M., Eberle, F., Seitz, S., Mücke, N., Hüber, C. M., Kiani, N. A., Kaderali, L., Lohmann, V., Dalpke, A. H., & Bartenschlager, R. F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256974 · Cited by 125 · see citing works
Franklin, B. S., Ishizaka, S. T., Lamphier, M. S., Gusovsky, F., Hansen, H. F., Rose, J., Zheng, W., Ataide, M. A., de Oliveira, R. B., Golenbock, D. T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015406108 · Cited by 123 · see citing works
Cekaite, L., Furset, G., Hovig, E. J., & Sioud, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.034 · Cited by 121 · see citing works
Dalpke, A. H., Zimmermann, S., Albrecht, I., & Heeg, K. M. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01410.x · Cited by 120 · see citing works
Tumor vaccination using messenger RNA: prospects of a future therapy
Kreiter, S., Diken, M., Selmi, A., Türeci, Ö., & Şahin, U. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.007 · Cited by 120 · see citing works
Jöckel, S., Nees, G., Sommer, R., Zhao, Y., Cherkasov, D., Hori, H., Ehm, G., Schnare, M., Nain, M., Kaufmann, A. M., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111075 · Cited by 120 · see citing works
On the wobble GoU and related pairs
Masquida, B., & Westhof, É. (2000) · RNA · doi:10.1017/s1355838200992082 · Cited by 119 · see citing works
Koski, G. K., Karikó, K., Xu, S., Weissman, D., Cohen, P. A., & Czerniecki, B. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.3989 · Cited by 116 · see citing works
Bourgeois, C., Majer, O., Frohner, I. E., Lesiak-Markowicz, I., Hildering, K.-S., Glaser, W., Stockinger, S., Decker, T., Akira, S., Müller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002599 · Cited by 116 · see citing works
Accessing the therapeutic potential of immunostimulatory nucleic acids
Barchet, W., Wimmenauer, V., Schlee, M., & Hartmann, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.007 · Cited by 109 · see citing works
Therapeutic anti‐tumor immunity triggered by injections of immunostimulating single‐stranded RNA
Scheel, B., Aulwurm, S., Probst, J., Stitz, L., Hoerr, I., Rammensee, H., Weller, M., & Pascolo, S. (2006) · European Journal of Immunology · doi:10.1002/eji.200635910 · Cited by 108 · see citing works
Modifications in Small Interfering RNA That Separate Immunostimulation from RNA Interference
Eberle, F., Gießler, K., Deck, C., Heeg, K. M., Peter, M. E., Richert, C., & Dalpke, A. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3229 · Cited by 103 · see citing works
Ablasser, A., Poeck, H., Anz, D., Berger, M., Schlee, M., Kim-Hellmuth, S., Bourquin, C., Goutagny, N., Jiang, Z., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803001 · Cited by 103 · see citing works
Deleavey, G. F., Watts, J. K., Alain, T., Robert, F., Kalota, A., Aishwarya, V., Pelletier, J., Gewirtz, A. M., Sonenberg, N., & Damha, M. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq181 · Cited by 95 · see citing works
Recognition of yeast nucleic acids triggers a host‐protective type I interferon response
Biondo, C., Signorino, G., Costa, A., Midiri, A., Gerace, E., Galbo, R., Bellantoni, A., Malara, A., Beninati, C., Teti, G., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141490 · Cited by 93 · see citing works
Hamm, S., Latz, E., Hangel, D., Müller, T. R., Yu, P., Golenbock, D. T., Sparwasser, T. D., Wagner, H., & Bauer, S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.09.003 · Cited by 90 · see citing works
Peter, M. E., Kubarenko, A. V., Weber, A. N. R., & Dalpke, A. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900819 · Cited by 90 · see citing works
CpG RNA: Identification of Novel Single-Stranded RNA That Stimulates Human CD14+CD11c+ Monocytes
Sugiyama, T., Gürsel, M., Takeshita, F., Coban, C., Conover, J., Kaisho, T., Akira, S., Klinman, D. M., & Ishii, K. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2273 · Cited by 80 · see citing works
Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8
Lan, T., Kandimalla, E. R., Yu, D. S., Bhagat, L., Li, Y., Wang, D., Zhu, F., Tang, J. X., Putta, M. R., Cong, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706059104 · Cited by 75 · see citing works
Bacterial RNA is recognized by different sets of immunoreceptors
Eberle, F., Sirin, M., Binder, M., & Dalpke, A. H. (2009) · European Journal of Immunology · doi:10.1002/eji.200838978 · Cited by 75 · see citing works
Rational Design of Immunostimulatory siRNAs
Gantier, M. P., Tong, S. Y. C., Behlke, M. A., Irving, A. T., Lappas, M., Nilsson, U. W., Latz, E., McMillan, N. A. J., & Williams, B. R. G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.4 · Cited by 74 · see citing works
A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation
Pirher, N., Ivičak‐Kocjan, K., Pohar, J., Benčina, M., & Jerala, R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1453 · Cited by 70 · see citing works
Macrophages recognize streptococci through bacterial single‐stranded RNA
Deshmukh, S. D., Kremer, B., Freudenberg, M. A., Bauer, S., Golenbock, D. T., & Henneke, P. (2010) · EMBO Reports · doi:10.1038/embor.2010.189 · Cited by 68 · see citing works
Lacoux, C., Marino, D. D., Boyl, P. P., Zalfa, F., Yan, B., Ciotti, M. T., Falconi, M., Urlaub, H., Achsel, T., Mougin, A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1254 · Cited by 67 · see citing works
DNA binding to proteolytically activated TLR9 is sequence‐independent and enhanced by DNA curvature
Li, Y., Berke, I. C., & Modis, Y. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.441 · Cited by 66 · see citing works
Nucleic Acid-Sensing TLRs as Modifiers of Autoimmunity
Deane, J. A., & Bolland, S. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6573 · Cited by 65 · see citing works
UNC93B1 Mediates Host Resistance to Infection with Toxoplasma gondii
Melo, M. B., Kasperkovitz, P. V., Cerny, A., Könen‐Waisman, S., Kurt‐Jones, E. A., Lien, E., Beutler, B., Howard, J. C., Golenbock, D. T., & Gazzinelli, R. T. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001071 · Cited by 65 · see citing works
Homology modeling of human Toll‐like receptors TLR7, 8, and 9 ligand‐binding domains
Wei, T., Gong, J., Jamitzky, F., Heckl, W. M., Stark, R. W., & Rössle, S. C. (2009) · Protein Science · doi:10.1002/pro.186 · Cited by 65 · see citing works
Hokeness, K. L., Crane, M. J., Dragoi, A. M., Chu, W., & Salazar‐Mather, T. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6176 · Cited by 53 · see citing works
Khairuddin, N., Gantier, M. P., Blake, S. J., Wu, S. Y., Behlke, M. A., Williams, B. R. G., & McMillan, N. A. J. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.19 · Cited by 48 · see citing works
Furset, G., & Sioud, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.059 · Cited by 47 · see citing works
Chen, S.-Y., Shiau, A.-L., Li, Y. T., Lin, Y.-S., Lee, C.-H., Wu, C., & Wang, C.-R. (2011) · Gene Therapy · doi:10.1038/gt.2011.173 · Cited by 36 · see citing works
Does the understanding of immune activation by RNA predict the design of safe siRNAs?
Sioud, M. (2008) · Frontiers in bioscience · doi:10.2741/3011 · Cited by 35 · see citing works
Dual or Triple Activation of TLR7, TLR8, and/or TLR9 by Single-Stranded Oligoribonucleotides
Forsbach, A., Samulowitz, U., Völp, K., Hofmann, H.-P., Noll, B. O., Tluk, S., Schmitz, C., Wader, T., Müller, C., Podszuweit, A., et al. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0323 · Cited by 34 · see citing works
Characterization of Conserved Viral Leader RNA Sequences That Stimulate Innate Immunity through TLRs
Forsbach, A., Némorin, J.-G., Völp, K., Samulowitz, U., Montino, C., Müller, C., Tluk, S., Hamm, S., Bauer, S., Lipford, G. B., et al. (2007) · Oligonucleotides · doi:10.1089/oli.2007.0098 · Cited by 34 · see citing works
Fukuda, K., Watanabe, T., Tokisue, T., Tsujita, T., Nishikawa, S., Hasegawa, T., Seya, T., & Matsumoto, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802284200 · Cited by 33 · see citing works
Antiviral activity of polynucleotides: Role of the 2′‐hydroxyl and a pyrimidine 5‐methyl
Clercq, E. D., Zmudzka, B. Z., & Shugar, D. (1972) · FEBS Letters · doi:10.1016/0014-5793(72)80845-7 · Cited by 31 · see citing works
Lan, T., Dai, M., Wang, D., Zhu, F., Kandimalla, E. R., & Agrawal, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901145s · Cited by 27 · see citing works
Lan, T., Putta, M. R., Wang, D., Dai, M., Yu, D. S., Kandimalla, E. R., & Agrawal, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.036 · Cited by 27 · see citing works
Phosphorothioation of DNA in bacteria
Eckstein, F. (2007) · Nature Chemical Biology · doi:10.1038/nchembio1107-689 · Cited by 23 · see citing works
Avril, T., de Tayrac, M., Leberre, C., & Quillien, V. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31819d29bf · Cited by 22 · see citing works
Phosphorothioate-Stimulated Uptake of siRNA by Mammalian Cells: A Novel Route for Delivery
Detzer, A., & Sczakiel, G. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630884 · Cited by 22 · see citing works
Flagged first, then by citations
1 of the 193 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551 · see citing works
The growth of siRNA-based therapeutics: updated clinical studies
Zhang, M. M., Bahal, R., Rasmussen, T. P., Manautou, J. E., & Zhong, X.-B. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114432 · Cited by 497 · see citing works
MicroRNAs in Cardiovascular Disease
Barwari, T., Joshi, A., & Mayr, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.945 · Cited by 447 · see citing works
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Yu, A., Choi, Y. H., & Tu, M. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019554 · Cited by 405 · see citing works
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Chung, Y. H., Beiss, V., Fiering, S., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07197 · Cited by 341 · see citing works
RNA therapy: rich history, various applications and unlimited future prospects
Kim, Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00757-5 · Cited by 266 · see citing works
Kwon, H., Kim, M., Seo, Y., Moon, Y. S., Lee, H. J., Lee, K., & Lee, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.034 · Cited by 208 · see citing works
RNA therapy: Are we using the right molecules?
Yu, A., Jian, C., Yu, A. H., & Tu, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.011 · Cited by 162 · see citing works
Schaefer, M., Kapoor, U., & Jantsch, M. F. (2017) · Open Biology · doi:10.1098/rsob.170077 · Cited by 152 · see citing works
Rosero, W. A. A., Barbezan, A. B., de Souza, C. D., & Rostelato, M. E. C. M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020255 · Cited by 146 · see citing works
Oberbauer, V., & Schaefer, M. (2018) · Genes · doi:10.3390/genes9120607 · Cited by 119 · see citing works
RNA Modifications Modulate Activation of Innate Toll-Like Receptors
Freund, I., Eigenbrod, T., Helm, M., & Dalpke, A. H. (2019) · Genes · doi:10.3390/genes10020092 · Cited by 119 · see citing works
RNA nucleotide methylation: 2021 update
Motorin, Y., & Helm, M. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1691 · Cited by 102 · see citing works
Antiviral and Immunomodulatory Properties of Antimicrobial Peptides Produced by Human Keratinocytes
Chessa, C., Bodet, C., Jousselin, C., Wehbe, M., Lévêque, N., & Garcia, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01155 · Cited by 99 · see citing works
Current and future nanoparticle vaccines for COVID-19
Vu, M. N., Kelly, H. G., Kent, S. J., & Wheatley, A. K. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103699 · Cited by 97 · see citing works
Efficient RNA virus control in Drosophila requires the RNA methyltransferase Dnmt2
Durdevic, Z., Hanna, K., Gold, B., Pollex, T., Cherry, S. R., Lyko, F., & Schaefer, M. (2013) · EMBO Reports · doi:10.1038/embor.2013.3 · Cited by 97 · see citing works
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
Bayraktar, E., Bayraktar, R., Öztatlıcı, H., Lopez‐Berestein, G., Amero, P., & Rodriguez‐Aguayo, C. (2023) · Non-Coding RNA · doi:10.3390/ncrna9020027 · Cited by 86 · see citing works
The double-edged sword of H19 lncRNA: Insights into cancer therapy
Lim, Y. W. S., Xiang, X., Garg, M., Le, M. T. N., Wong, A. L., Wang, L., & Goh, B.-C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.006 · Cited by 84 · see citing works
Sittplangkoon, C., Alameh, M.-G., Weissman, D., Lin, P. J. C., Tam, Y. K., Prompetchara, E., & Palaga, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983000 · Cited by 79 · see citing works
Pharmacokinetics and Pharmacodynamics of GalNAc‐Conjugated siRNAs
An, G. (2023) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2337 · Cited by 85 · see citing works
Therapeutic promise of engineered nonsense suppressor tRNAs
Porter, J. J., Heil, C. S., & Lueck, J. D. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1641 · Cited by 71 · see citing works
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
Veiga, N., Diesendruck, Y., & Peer, D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.002 · Cited by 74 · see citing works
Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?
Szulc‐Dąbrowska, L., Bossowska-Nowicka, M., Struzik, J., & Toka, F. N. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.601072 · Cited by 70 · see citing works
Wang, Z., Cui, K., Costabel, U., & Zhang, X. (2022) · Exploration · doi:10.1002/exp.20210082 · Cited by 66 · see citing works
RNA 5-Methylcytosine Analysis by Bisulfite Sequencing
Schaefer, M. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.03.007 · Cited by 64 · see citing works
tRNA modifications: Necessary for correct tRNA‐derived fragments during the recovery from stress?
Durdevic, Z., & Schaefer, M. (2013) · BioEssays · doi:10.1002/bies.201200158 · Cited by 53 · see citing works
Khan, N., Chen, X., & Geiger, J. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595888 · Cited by 50 · see citing works
Zhang, X., Gao, R., Zhang, C., Teng, Y., Chen, H., Li, Q., Liu, C., Wu, J., Wei, L., Deng, L., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01543-z · Cited by 49 · see citing works
Galvanin, A., Vogt, L., Grober, A., Freund, I., Ayadi, L., Bourguignon‐Igel, V., Bessler, L., Jacob, D., Eigenbrod, T., Marchand, V., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1123 · Cited by 47 · see citing works
Coagulation Disorders in COVID-19: Role of Toll-like Receptors
Biswas, I., & Khan, G. A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s271768 · Cited by 44 · see citing works
Fa, H., Chang, W., Zhang, X.-J., Xiao, D., & Wang, J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0471-x · Cited by 43 · see citing works
Chen, C., Gao, R., Li, M., Wang, Q., Chen, H., Zhang, S., Mao, X., Behensky, A. A., Zhang, Z., Gan, L., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.024 · Cited by 38 · see citing works
Toonen, L. J. A., Casaca-Carreira, J., Pellisé-Tintoré, M., Mei, H., Temel, Y., Jahanshahi, A., & van Roon‐Mom, W. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0705 · Cited by 36 · see citing works
Korzun, T., Moses, A. S., Diba, P., Sattler, A. L., Taratula, O. R., Sahay, G., Taratula, O., & Marks, D. L. (2023) · Pharmaceuticals · doi:10.3390/ph16081088 · Cited by 37 · see citing works
Rhabdomyolysis Secondary to COVID-19 Vaccination
Mack, M., Nichols, L., & Guerrero, D. M. (2021) · Cureus · doi:10.7759/cureus.15004 · Cited by 35 · see citing works
Keller, P., Freund, I., Marchand, V., Bec, G., Huang, R., Motorin, Y., Eigenbrod, T., Dalpke, A. H., & Helm, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky644 · Cited by 33 · see citing works
Nanoparticles and Antiviral Vaccines
Liu, S., Hu, M., Liu, X., Liu, X., Chen, T., Zhu, Y., Liang, T., Xiao, S., Li, P., & Ma, X. (2023) · Vaccines · doi:10.3390/vaccines12010030 · Cited by 33 · see citing works
miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities
Huang, W., Paul, D., Călin, G. A., & Bayraktar, R. (2023) · Cells · doi:10.3390/cells13010084 · Cited by 33 · see citing works
A modified dinucleotide motif specifies tRNA recognition by TLR7
Kaiser, S., Rimbach, K., Eigenbrod, T., Dalpke, A. H., & Helm, M. (2014) · RNA · doi:10.1261/rna.044024.113 · Cited by 31 · see citing works
Li, Q., & Kang, C. (2023) · FEBS Letters · doi:10.1002/1873-3468.14710 · Cited by 28 · see citing works
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
Starostina, E. V., Sharabrin, S. V., Antropov, D. N., Stepanov, G. A., Shevelev, G. Y., Lemza, A. E., Рудометов, А. П., Borgoyakova, M. B., Борисовна, Р. Н., Marchenko, V. Y., et al. (2021) · Vaccines · doi:10.3390/vaccines9050452 · Cited by 28 · see citing works
RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases
Salem, E., Vonberg, A. D., Borra, V. J., Gill, R. K., & Nakamura, T. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00106 · Cited by 26 · see citing works
Park, K., Svennerholm, K., Crescitelli, R., Lässer, C., Gribonika, I., Andersson, M., Boström, J., Alalam, H., Harandi, A. M., Farewell, A., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01928-w · Cited by 26 · see citing works
Inhibition of antigen presentation by Brucella: many more than many ways
Barrionuevo, P., & Giambartolomei, G. H. (2019) · Microbes and Infection · doi:10.1016/j.micinf.2018.12.004 · Cited by 26 · see citing works
Ng, B., Cash-Mason, T., Wang, Y., Seitzer, J. L., Burchard, J., Brown, D., Dudkin, V., Davide, J. P., Jadhav, V., Sepp‐Lorenzino, L., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.013 · Cited by 27 · see citing works
Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
Rubio‐Casillas, A., Cowley, D., Raszek, M., Uversky, V. N., & Redwan, E. M. M. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131427 · Cited by 24 · see citing works
Elkhalifa, D. H., Rayan, M., Negmeldin, A. T., Elhissi, A. M. A., & Khalil, A. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112385 · Cited by 23 · see citing works
Advancements in RNA-based therapies from bench to bedside
Singh, A., Tekade, M., Nagaraja, S., Bharti, A., & Tekade, R. K. (2026) · npj Drug Discovery. · doi:10.1038/s44386-025-00037-y · Cited by 23 · see citing works
Milillo, M. A., Velásquez, L. N., Trotta, A., Delpino, M. V., Marinho, F. V., Balboa, L., Vermeulen, M. E., Espíndola, S. L., Rodriguez‐Rodrigues, N., Fernández, G. C., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006527 · Cited by 22 · see citing works
Identification of U11snRNA as an endogenous agonist of TLR7-mediated immune pathogenesis
Negishi, H., Endo, N., Nakajima, Y., Nishiyama, T., Tabunoki, Y., Nishio, J., Koshiba, R., Matsuda, A., Matsuki, K., Okamura, T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915326116 · Cited by 22 · see citing works
Herath, K. H. I. N. M., Mihindukulasooriya, S. P., Kim, H. J., Kim, A., Kim, H. J., Jeon, Y., & Jee, Y. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103991 · Cited by 19 · see citing works
Polymeric Carriers for Delivery of RNA Cancer Therapeutics
Mirón‐Barroso, S., Correia, J. S., Frampton, A. E., Lythgoe, M. P., Clark, J., Tookman, L. A., Ottaviani, S., Castellano, L., Porter, A. E., Georgiou, T. K., et al. (2022) · Non-Coding RNA · doi:10.3390/ncrna8040058 · Cited by 18 · see citing works
RNA–lipid nanoparticles for acute critical illnesses
Omo‐Lamai, S., Zamora, M. E., Mueller, B. K., Casciano, J. C., & Brenner, J. S. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00314-5 · Cited by 17 · see citing works
CoverageAnalyzer (CAn): A Tool for Inspection of Modification Signatures in RNA Sequencing Profiles
Hauenschild, R., Werner, S., Tserovski, L., Hildebrandt, A., Motorin, Y., & Helm, M. (2016) · Biomolecules · doi:10.3390/biom6040042 · Cited by 17 · see citing works
Variable presence of 5-methylcytosine in commercial RNA and DNA
Schmid, K., Thüring, K. L., Keller, P., Ochel, A., Kellner, S. M., & Helm, M. (2015) · RNA Biology · doi:10.1080/15476286.2015.1076612 · Cited by 16 · see citing works
Durdevic, Z., & Schaefer, M. (2013) · BioEssays · doi:10.1002/bies.201300088 · Cited by 15 · see citing works
Streptococcus mutans-derived extracellular vesicles promote skin wound healing via tRNA cargo
Oh, S. Y., Kim, D., Lee, K. Y., Ha, D., Kim, T.-L., Kwon, T., Kim, J. W., Lee, H., Choi, S., & Hong, S. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03410-1 · Cited by 15 · see citing works
A Self-Assembling Short Oligonucleotide Duplex Suitable for Pretargeting
Mallikaratchy, P. R., Gardner, J., Nordstrøm, L. U., Veomett, N. J., McDevitt, M. R., Heaney, M. L., & Scheinberg, D. A. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0425 · Cited by 14 · see citing works
Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 Vaccines
Xu, Y., Ferguson, T., Masuda, K., Siddiqui, M. A., Smith, K. P., Vest, O., Brooks, B., Zhou, Z., Obliosca, J. M., Kong, X., et al. (2023) · Biomolecules · doi:10.3390/biom13071088 · Cited by 13 · see citing works
Cérda, S. L., Molinaro, G., Tello, R. P., Correia, A., Künig, S., Steinberger, P., Jeltsch, M., Hirvonen, J. J., Barreto, G., Stöckl, J., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c02363 · Cited by 13 · see citing works
Implication of myddosome complex genetic variants in outcome severity of COVID-19 patients
Martínez-Gómez, L. E., Martínez-Armenta, C., Medina-Luna, D., Ordóñez-Sánchez, M. L., Tusié‐Luna, T., Ortega‐Peña, S., Herrera-López, B., Suárez-Ahedo, C., Jiménez-Gutiérrez, G. E., Hidalgo‐Bravo, A., et al. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.06.002 · Cited by 11 · see citing works
Targeting RNA-binding proteins with small molecules: perspectives and challenges
Konde, O. M., Balela, W. B., & Tshitenge, T. B. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1649692 · Cited by 11 · see citing works
Zam, A., Rouatbi, N., Walters, A. A., & Al‐Jamal, K. T. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115759 · Cited by 12 · see citing works
Karpagavalli, M., Sindal, M. D., Arunachalam, J. P., & Chidambaram, S. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110236 · Cited by 10 · see citing works
Helmy, S. A., Morsi, R. M. E., El-Masry, S. M., & El-Masry, S. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103762 · Cited by 12 · see citing works
Success of nano-vaccines against COVID-19: a transformation in nanomedicine
Sarangi, M., Padhi, S., Rath, G., Nanda, S. S., & Yi, D.-K. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2148659 · Cited by 8 · see citing works
Bioconjugation of Small Molecules to RNA Impedes Its Recognition by Toll-Like Receptor 7
Hellmuth, I., Freund, I., Schlöder, J., Seidu‐Larry, S., Thüring, K. L., Slama, K., Langhanki, J., Kaloyanova, S. S., Eigenbrod, T., Krumb, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00312 · Cited by 10 · see citing works
Kishimoto, M., Ishikawa, T., & Odawara, M. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0629 · Cited by 9 · see citing works
Noncoding RNAs in cataract formation: Star molecules emerge in an endless stream
Chen, S., Zhang, C., Shen, L., Hu, J., Chen, X., & Yu, Y. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106417 · Cited by 10 · see citing works
Let-7b-TLR7 Signaling Axis Contributes to the Anesthesia/Surgery-Induced Cognitive Impairment
Deng, L., Gao, R., Chen, H., Jiao, B., Zhang, C., Wei, L., Yan, C., Ye, S., Zhu, T., & Chen, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03658-4 · Cited by 9 · see citing works
Vaccine development and technology for SARS‐CoV‐2: Current insight
Cattel, L., Giordano, S., Traina, S., Lupia, T., Corcione, S., Angelone, L., Valle, G. L., Rosa, F. G. D., & Cattel, F. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27425 · Cited by 8 · see citing works
Role of Nanomaterials in COVID-19 Prevention, Diagnostics, Therapeutics, and Vaccine Development
Patel, U., Rathnayake, K., Hunt, E. C., & Singh, N. (2022) · Journal of Nanotheranostics · doi:10.3390/jnt3040011 · Cited by 9 · see citing works
ASTHMA AND COVID-19: THE EOSINOPHILIC LINKPreprint
Rodríguez, C., & Veciana, C. (2020) · doi:10.32388/5iy4if · Cited by 9 · see citing works
Fan, J., Xiao, Z., Dong, Y., Ye, F., Yan, Q., Zhang, C., Yin, X., Li, Y., & Wang, T. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402933 · Cited by 7 · see citing works
Virus sensing receptors in cellular infectivity of influenza A virus
Almatrrouk, S., Saba, I., Abozaid, S. M., Al-Qahtani, A. A., & Al‐Ahdal, M. N. (2021) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.13258 · Cited by 7 · see citing works
Moradian, H., Dunne, C. M., Gossen, M., & Hartlieb, M. (2025) · Advanced Science · doi:10.1002/advs.202512653 · Cited by 6 · see citing works
Ranjan, S., & Panda, A. K. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10600-9 · Cited by 6 · see citing works
Krieger, J., Stifter, K., Riedl, P., & Schirmbeck, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-32971-5 · Cited by 5 · see citing works
Comparison of the Class Effects of Antisense Oligonucleotides in CByB6F1-Tg(HRAS)2Jic and CD-1 Mice
Kim, T., Papagiannis, C. N., Zwick, L. S., Engelhardt, J. A., Hoffmaster, C. M., Post, N. M., Matson, J. E., Hsiao, J., Burel, S. A., & Henry, S. P. (2018) · Toxicologic Pathology · doi:10.1177/0192623318813143 · Cited by 4 · see citing works
Prokaryotic RNA activates endothelial cells promoting neutrophil transmigration
Castillo, L. A., Birnberg-Weiss, F., Rodriguez‐Rodrigues, N., Pittaluga, J. R., Martire‐Greco, D., Milillo, M. A., Grinstein, S. F., Camelli, M. R., Aybar, A. J. M., Landoni, V. I., et al. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12282 · Cited by 4 · see citing works
Microbial RNA, the New PAMP of Many Faces
Milillo, M. A., Velásquez, L. N., & Barrionuevo, P. (2022) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2022.924719 · Cited by 4 · see citing works
Pulmonary Delivery of Messenger RNA (mRNA) Therapeutics for Respiratory Diseases
Qiu, Y., Chow, M. Y. T., & Lam, J. K. W. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_7 · Cited by 4 · see citing works
Parry, J. D., Harper, T. A., Andersson, P. U., Elloway, J. M., Holman, N. S., Achanzar, W. E., Lynch, A. M., Tessier, Y., Crosby, M. E., Floettmann, E., et al. (2025) · Nucleic Acid Therapeutics · doi:10.1089/nat.2024.0075 · Cited by 3 · see citing works
Yang, B., & Ge, Z. (2025) · Molecular Pain · doi:10.1177/17448069251346373 · Cited by 3 · see citing works
A Critical Assessment of COVID-19 Genomic Vaccines
Sabbah, D. A., Hajjo, R., & Sunoqrot, S. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230825094341 · Cited by 3 · see citing works
Enhanced Expression of TLR8 in Placental Tissue in Preeclampsia
Nizyaeva, N. V., Amiraslanov, A. E. Y., Анатольевна, Л. Н., Savelyeva, N. A., Pavlovich, S. V., Nagovitsyna, М. N., & Щеголев, А. И. (2020) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-020-04717-9 · Cited by 3 · see citing works
siRNA Therapeutics to Treat Liver Disorders
Lai, C.-J., Martín-Higueras, C., & SALIDO, E. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53457-2_8 · Cited by 3 · see citing works
Toll-Like Receptor Dysregulation in The Hospitalized COVID-19 Patients
Kamiab, Z., Arababadi, M. K., Bahrehmand, F., Bazmandegan, G., Sayadi, A. R., & Abbasifard, M. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_287_22 · Cited by 2 · see citing works
Baker, C. P., Laba, S., Warner, J., Shepherd, K., Wilson, H. M., & Arthur, J. S. C. (2026) · Scientific Reports · doi:10.1038/s41598-026-39429-z · Cited by 3 · see citing works
In vitro transcribed circRNA as a therapeutic agent for cancer
Xu, S., Zhao, Y., Tang, Y., Fu, G., Qian, C., Li, F., Yang, Z., Cui, W., & Cai, W. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.04.019 · Cited by 2 · see citing works
Interaction of Ebola Virus with the Innate Immune System
Yousefi, P., & Tabibzadeh, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104843 · Cited by 2 · see citing works
Pygmy MicroRNA: Surveillance Cops in Therapy Kingdom
Bhadra, U., Patra, P., Chhatai, J., & Pal‐Bhadra, M. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00136 · Cited by 2 · see citing works
miR-3132 upregulates surface TRAIL to induce apoptotic cell death in cancer cells.
Lulla, A. R., Zhou, Y., Ralff, M. D., Lev, A., Dicker, D. T., & El‐Deiry, W. S. (2022) · PubMed Central · Cited by 2 · see citing works
Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs Against COVID-19
Paschall, A. V., & Avci, F. Y. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839162572-00112 · Cited by 1 · see citing works
RNA-based Therapeutics: Master Regulator for Bioengineering Systems in Medicine World
Singla, R., Arora, M., & Bansal, P. (2023) · Current Biotechnology · doi:10.2174/2211550112666230417100541 · Cited by 1 · see citing works
TLR3 regulation and cytokine response during BoAHV-1 and BoAHV-5 infection of neuronal-like cells
Brunner, M. B., Rosales, J. J., Ladera, M., Farías, M. V. N., Verna, A., & Pérez, S. (2025) · Microbes and Infection · doi:10.1016/j.micinf.2025.105558 · Cited by 1 · see citing works
A Case of Glycogen Storage Disease Type V with Rhabdomyolysis after COVID-19 Vaccination
Kim, H., Kim, Y.-E., & Lee, H. L. (2021) · Korean Journal of Neuromuscular Disorders · doi:10.46518/kjnmd.2021.13.2.55 · Cited by 1 · see citing works
Tabibzadeh, A., Niya, M. H. K., Keyvani, H., Karampoor, S., Yousefi, P., Razizadeh, M. H., Jwaziri, A. K., Khamseh, J., & Esghaei, M. (2022) · Immunopathologia Persa · doi:10.34172/ipp.2022.32405 · Cited by 1 · see citing works
Giese, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-25832-4_2 · Cited by 1 · see citing works
Biomolecular Therapeutics for HIV
Li, S., & Burnett, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00018-5 · Cited by 1 · see citing works
- Authors
- Dalpke, A. H., & Helm, M.
- Affiliations
- Heidelberg University (DE)
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Helm, Mark
- Venue
- RNA Biology
- Publisher
- Informa UK Limited
- Published
- 2012-06
- Volume
- 9
- Issue
- 6
- Pages
- 828-842
- ISSN
- 1547-6286 (ISSN-L)
- 1555-8584
- PMC
- PMC3495747
- OpenAlex
- W1994331999
- Cited by
- 113
- References
- 193
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 5 · 2023: 16 · 2022: 16 · 2021: 12 · 2020: 13 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 5
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- RNA Biology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Invertebrate Immune Response Mechanisms
- Keywords
- Toll-like receptors, RNA sensing, pattern recognition receptors, innate immunity, bacterial RNA, nucleic acid recognition, autoimmune disease, infection susceptibility
- MeSH terms
- Animals, Autoimmune Diseases, Bacteria, Bacterial Infections, Base Sequence, DNA, Bacterial, Humans, Immunity, Innate, Nucleic Acid Conformation, Protein Binding, RNA, Bacterial, RNA, Small Interfering, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review